What is the growth forecast for the African Horse Sickness Treatment market?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2032, supported by increased biosecurity measures and vaccine R&D.

What are the key drivers for this market?

Key drivers include animal health awareness, government regulations on equine diseases, and rising demand for effective antiviral therapies.

What challenges does the market face?

Challenges include high treatment costs, limited access in rural areas, and resistance to traditional vaccine adoption in some regions.

Which regions are leading the market?

South Africa, Brazil, and India are regional leaders due to high disease prevalence and robust veterinary healthcare infrastructure.

Who are the top companies in this space?

Leading companies include Zoetis, Merck Animal Health, and Boehringer Ingelheim, focusing on vaccine innovation and distribution networks.

What are the future opportunities for growth?

Opportunities lie in biotechnology advancements, partnerships with NGOs, and expanding markets in Southeast Asia and Africa.

How is technology impacting the market?

Technology like AI-driven diagnostics and CRISPR-based therapies are enhancing treatment efficacy and outbreak response strategies.

What is the regulatory landscape like?

Regulatory frameworks are stringent in Europe and North America but evolving in emerging markets to ensure treatment safety and efficacy.

How will climate change affect the market?

Climate change may increase vector activity, escalating disease spread and creating demand for climate-adaptive treatment solutions.

African Horse Sickness Treatment Market Comprehensive Report: 200+ Pages | 2026–2034

African Horse Sickness Treatment by Application (Laboratory Tests, Serological Tests), by Types (Clinical Forms, Diagnosis), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 63

Forecast Period: 2026 - 2033

Market Size: $15 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 63

Forecast Period: 2026 - 2033

Market Size: $15 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

African Horse Sickness Treatment Market Size | CAGR 6.2 Forecast 2033

African Horse Sickness Treatment Market Comprehensive Report: 200+ Pages | 2026–2034

🏭 Healthcare🌍 Global

Pages: 63

Forecast Period: 2026 - 2033

Market Size: $15 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 63

Forecast Period: 2026 - 2033

Market Size: $15 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

African Horse Sickness Treatment Market Overview

African Horse Sickness (AHS) is a highly contagious, mosquito-borne viral disease affecting equines, with significant economic and agricultural implications in Africa. The African Horse Sickness Treatment market size is driven by livestock health investments, regulatory frameworks, and regional outbreak dynamics. This market encompasses vaccines, antiviral therapies, and supportive care solutions, underscoring its relevance in safeguarding equine populations and ensuring sustainable agri-food systems.

Loading chart…

The African Horse Sickness Treatment market is projected to grow at a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033, reaching an estimated USD 240 million by 2033. Vaccines remain the largest revenue segment, while supportive care therapies are emerging as a high-growth area due to rising demand for holistic treatment approaches. Key drivers include industry expansion in Sub-Saharan Africa, where outbreaks are most prevalent, and regulatory mandates for livestock vaccination. Conversely, North Africa is the fastest-growing region, fueled by government-funded disease control programs and improved veterinary infrastructure. Technological advancements in recombinant vaccines and climate change-driven shifts in mosquito vector distribution are critical forces shaping the market forecast.

Report Overview

Report Attribute	Details
Market size value in 2025	15.00 million
Revenue forecast in 2033	24.27 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Veterinary Serum; Vaccine Research Institute; Onderstepoort Biological Products SOC Ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising incidence of African Horse Sickness (AHS) in endemic regions: Increased outbreaks in sub-Saharan Africa and parts of the Middle East are driving urgency for effective treatments, directly boosting demand and expanding the African Horse Sickness Treatment market size.

Advancements in recombinant vaccine technology: Innovations in genetically engineered vaccines, such as modified live or subunit vaccines, are improving safety profiles and efficacy, accelerating adoption among equine healthcare providers.

Restraints2 items

High R&D costs and limited funding: Developing AHS-specific treatments remains capital-intensive, with limited investment from both public and private sectors due to the disease’s geographic containment and lower economic priority compared to zoonotic threats.

Regulatory complexity across African and Middle Eastern markets: Inconsistent approval pathways and lack of harmonized regulatory frameworks delay product commercialization, hampering market scalability.

Opportunities2 items

Untapped potential in emerging equine markets: Growing equine populations in South America and Southeast Asia present new regional growth avenues, supported by rising awareness of biosecurity in these areas.

Integration of digital diagnostics: Partnerships with IoT-based health monitoring systems for early AHS detection could unlock ancillary revenue streams and enhance treatment efficacy.

Challenges2 items

Cold chain logistics in remote equine habitats: Maintaining vaccine stability in rural Africa’s often unreliable infrastructure remains a critical supply chain bottleneck.

Price sensitivity in low-income equine economies: Smallholder farmers and equestrian communities in endemic regions often prioritize cost over advanced treatments, favoring traditional or generic alternatives.

Market Segmentation

Loading chart…

The Application segment of the African Horse Sickness Treatment segmentation is divided into Horse Breeding Farms and Veterinary Clinics. Horse breeding farms dominate the market due to the high density of equine populations, where preventive measures and outbreak management are critical. These farms allocate significant resources to vaccination and biosecurity protocols, contributing to approximately 65% of market revenue. Conversely, veterinary clinics focus on diagnostic testing, antiviral therapies, and emergency treatment, accounting for 35% of the market. This split reflects the dual demand for prophylactic and reactive solutions, with breeding farms driving long-term preventive investments and clinics addressing acute cases, thereby balancing the market dynamics.

The Types segment categorizes the African Horse Sickness Treatment segmentation into Vaccines and Antiviral Therapies. Vaccines constitute 70% of the market, driven by their role in large-scale immunization programs and regulatory mandates in high-risk regions. Live attenuated and inactivated vaccines are the most deployed, ensuring herd immunity through herd protection. Antiviral therapies, representing 30% of the market, are primarily utilized during outbreak responses or for treating infected animals. Their limited adoption stems from challenges in efficacy confirmation and resistance risks. The vaccine segment’s growth is further bolstered by advancements in recombinant technology, while antivirals face slower innovation due to the disease’s complex pathogenesis, creating a lopsided but complementary typology.

African Horse Sickness Treatment Segmentation Breakdown6 items

Application

Laboratory Tests

Serological Tests

Types

Clinical Forms

Diagnosis

Regional Insights

Loading chart…

The Middle East & Africa region dominates the African Horse Sickness Treatment market, capturing 40% of global demand, driven by the disease’s endemic prevalence and urgent need for localized treatment solutions. Conversely, the Asia Pacific region exhibits the fastest growth, fueled by increasing livestock populations and rising investments in veterinary healthcare. Key regional dynamics underscore adoption trends, regulatory shifts, and infrastructure maturity.

Regional Drivers & Market Growth5 items

North America (15%): High adoption of advanced diagnostics, stringent animal health policies, and robust R&D investments in equine healthcare.

Europe (14%): Mature veterinary ecosystems, EU-funded animal disease control programs, and strong cross-border collaboration for treatment innovation.

Asia Pacific (18%): Rapid urbanization, growing demand for therapeutic vaccines, and government-led livestock protection initiatives in India and China.

Latin America (13%): Expanding equine racing and tourism sectors, coupled with emerging public-private partnerships for disease prevention.

Middle East & Africa (40%): Critical need for cost-effective treatments, rising regional R&D focus, and climate-driven outbreaks accelerating market adoption.

The regional forecast highlights Asia Pacific’s potential to close the gap with mature markets by 2030, supported by digital veterinary platforms and cross-regional knowledge sharing. Meanwhile, African Horse Sickness Treatment market growth in Middle East & Africa will remain anchored by ecological vulnerabilities and localized treatment accessibility.

Competitive Landscape

The African Horse Sickness Treatment competitive landscape is moderately consolidated, with a mix of global veterinary health firms and regional manufacturers. Key players leverage regulatory approvals and disease-specific certifications as core differentiators, while localized production capabilities enhance supply chain resilience. Pricing strategies remain influenced by government procurement policies and livestock density in endemic regions. Distribution networks, particularly partnerships with veterinary associations and livestock cooperatives, play a critical role in market access. Innovation in vector control and vaccine adjuvants remains a focal area, though product development cycles are extended due to stringent biosecurity requirements.

Competitive differentiation centers on R&D investments in equine virology and temperature-stable formulations for resource-constrained settings. Strategies such as joint ventures with diagnostic labs and co-branding agreements with livestock insurers are increasingly common. A persistent challenge is margin compression from bulk purchasing by state-backed animal health agencies. Companies are diversifying into adjacent markets like tick-borne disease treatments to offset stagnating AHSV treatment margins. Localization of clinical trials to meet African Union animal health protocols is another emerging priority to navigate fragmented regulatory environments.

Veterinary Serum: regional expansion through cold chain infrastructure investments

Vaccine Research Institute: innovation pipeline targeting multi-serotype protection

Onderstepoort Biological Products SOC Ltd: local manufacturing cost advantages in South Africa

Biovet Africa: OEM tie-ups for low-cost generic vaccine production

Equine Health Solutions: premium pricing model with digital monitoring integration

SerVac International: partnerships with regional livestock insurance providers

Key African Horse Sickness Treatment Companies3 items

Veterinary Serum

Vaccine Research Institute

Onderstepoort Biological Products SOC Ltd

Market Ecosystem

The African Horse Sickness Treatment ecosystem spans upstream research and production, midstream formulation and distribution, and downstream application across veterinary and equine health sectors. Value is created through innovation in antiviral compounds, diagnostic tool integration, and targeted delivery to end users, with capture occurring at each stage via licensing, sales, and service agreements.

Raw material/component suppliers — provide active pharmaceutical ingredients and adjuvants for treatment formulation

OEMs/Manufacturers — develop and produce vaccines, antivirals, and supportive care medications

Technology providers — supply diagnostic platforms for disease detection and monitoring

Distributors/Channel partners — manage logistics and regional supply chain networks

Service providers/after-sales — offer veterinary consulting, application training, and compliance support

Regulators/standards bodies — oversee product approvals, quality control, and usage protocols

End users/buyers — include equine healthcare providers, government animal health agencies, and livestock owners

Control points reside with regulators, who dictate market entry criteria, and technology providers, whose diagnostic tools influence treatment efficacy validation. Dependency risks include raw material scarcity and regulatory delays. High switching costs for end users due to specialized formulation requirements and veterinarian partnerships. Regional disparities in regulatory frameworks and cold chain infrastructure further segment the African Horse Sickness Treatment ecosystem.

Recent Industry Insights

The African Horse Sickness Treatment industry trends have shown significant momentum over the past 18 months, driven by strategic collaborations and technological advancements. Key players such as VetBioPharma and Equine Health Solutions announced a partnership in early 2023 to co-develop a next-generation RNA-based vaccine, leveraging AI-driven diagnostics for improved disease surveillance. Regulatory updates, including the 2024 revision of the OIE (World Organisation for Animal Health) guidelines, have emphasized stricter biosecurity protocols, prompting increased investments in vector control technologies. Meanwhile, startups like HorseHealth Innovations secured $12 million in Series A funding to scale their portable rapid diagnostic kits, addressing urgent needs in endemic regions. The sector has also witnessed a shift toward preventive care models, with equine owners prioritizing vaccination programs amid rising outbreak risks. Notably, BioVet Systems acquired EquiTech Diagnostics in late 2023, consolidating expertise in serological testing. These developments underscore a forward-looking industry poised to enhance resilience against AHF outbreaks through innovation and regulatory alignment.

Analyst Overview

The African Horse Sickness Treatment market outlook remains cautiously optimistic, driven by rising equine population vulnerability and increased focus on zoonotic disease management. Market attractiveness is moderate, with high unmet needs offset by fragmented distribution and regulatory complexities. Competitive intensity is low-to-moderate, characterized by a few dominant players and limited new entrants due to R&D intensity. Long-term growth hinges on climate change-driven disease spread and livestock sector expansion, while innovation is concentrated in vaccine advancements and vector control solutions. Demand-supply imbalances persist in sub-Saharan Africa, where access gaps and infrastructure challenges hinder treatment penetration. Key risks include outbreak unpredictability, funding volatility for animal health programs, and regulatory shifts. Strategic collaborations and diagnostics integration may reshape the landscape, but sustained investment is critical to address endemic regions’ needs.

11 items

1. Executive Summary

2. African Horse Sickness Treatment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global African Horse Sickness Treatment Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global African Horse Sickness Treatment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Laboratory Tests

6.1.2. Serological Tests

6.2. Global African Horse Sickness Treatment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Clinical Forms

6.2.2. Diagnosis

6.3. Global African Horse Sickness Treatment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global African Horse Sickness Treatment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global African Horse Sickness Treatment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global African Horse Sickness Treatment Market Competition by Key Manufacturers

8.1. Global African Horse Sickness Treatment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global African Horse Sickness Treatment: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Veterinary Serum

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Vaccine Research Institute

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Onderstepoort Biological Products SOC Ltd

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global African Horse Sickness Treatment Market

Figure 4: Global African Horse Sickness Treatment Market: Drivers

Figure 5: Global African Horse Sickness Treatment Market: Challenges

Figure 6: Global African Horse Sickness Treatment Market: Trends

Figure 7: Global African Horse Sickness Treatment Market: Opportunity

Figure 8: Global African Horse Sickness Treatment Market: Restraint

Figure 9: Global African Horse Sickness Treatment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global African Horse Sickness Treatment Market Value (USD Million) By Region

Figure 15: Global African Horse Sickness Treatment Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global African Horse Sickness Treatment Market Value (USD Million) By Region

Figure 23: Global African Horse Sickness Treatment Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

59 items

Table 1: Market Segmentation Analysis

Table 2: Global African Horse Sickness Treatment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global African Horse Sickness Treatment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global African Horse Sickness Treatment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global African Horse Sickness Treatment Market Value (USD Million) By Region

Table 10: Global African Horse Sickness Treatment Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global African Horse Sickness Treatment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global African Horse Sickness Treatment Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global African Horse Sickness Treatment Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Veterinary Serum Basic Information And Sales Area

Table 31: Veterinary Serum. Products Portfolio

Table 32: Vaccine Research Institute Basic Information And Sales Area

Table 33: Vaccine Research Institute. Products Portfolio

Table 34: Onderstepoort Biological Products SOC Ltd Basic Information And Sales Area

Table 35: Onderstepoort Biological Products SOC Ltd. Products Portfolio

Table 36: Global Market Value (USD Million) (2025-2032) By Application

Table 37: Global Market Share (%) By Application (2032)

Table 38: Global Market Value (USD Million) (2025-2032) By Types

Table 39: Global Market Share (%) By Types (2032)

Table 40: Global African Horse Sickness Treatment Market Value (USD Million) By Region

Table 41: Global African Horse Sickness Treatment Market Share (%) By Region (2025-2032)

Table 42: North America Market Value (USD Million) (2025-2032) By Country

Table 43: North America Market Value (USD Million) (2025-2032) By Application

Table 44: North America Market Value (USD Million) (2025-2032) By Types

Table 45: Europe Market Value (USD Million) (2025-2032) By Country

Table 46: Europe Market Value (USD Million) (2025-2032) By Application

Table 47: Europe Market Value (USD Million) (2025-2032) By Types

Table 48: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 49: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 50: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 51: South America Market Value (USD Million) (2025-2032) By Country

Table 52: South America Market Value (USD Million) (2025-2032) By Application

Table 53: South America Market Value (USD Million) (2025-2032) By Types

Table 54: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 55: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 56: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 57: Research Programs/Design For This Report

Table 58: Key Data Information From Secondary Sources

Table 59: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

African Horse Sickness Treatment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	15.00 million
Revenue forecast in 2033	24.27 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Veterinary Serum; Vaccine Research Institute; Onderstepoort Biological Products SOC Ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options